According to the National Cancer Institute, immunotherapies that enlist and strengthen the power of a patient’s immune system are the “fifth pillar” of cancer treatment adding to surgery, chemotherapy ...
John Bertagnolli, vice-president of Commercial Operations at Selkirk Pharma, discusses considerations when building and scaling up pharmaceutical facilities, including contamination control and ...
—State-of-the-Art Facility Designed and Built Specifically for Pharmaceutical Contract Manufacturing, Featuring Advanced Fill/Finish Capabilities and Unidirectional Flow Technology— SPOKANE, ...
Selkirk Pharma, Inc., announced the Aseptic Process Simulation (APS) qualification of its sterile manufacturing facility and newly available fill/finish capacity. This development marks a significant ...
Dublin, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The "New EU (European Union) GMP (Good Manufacturing Practice) Annex 1: Compliant Aseptic Operations Training Course" conference has been added to ...
Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the ...
(MENAFN- GlobeNewsWire - Nasdaq) This course explores Annex 1's requirements, focusing on aseptic operations, CCS, and quality assurance. Attendees gain insights into regulatory expectations, ...
(MENAFN- GlobeNewsWire - Nasdaq) Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "New EU (European Union) GMP (Good Manufacturing Practice) Annex 1: Compliant Aseptic Operations Training Course" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback